查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1943688

豬保健市場－全球產業規模、佔有率、趨勢、機會及按類型、疾病、地區和競爭格局分類的預測（2021-2031年）

Swine Healthcare Market - Global Industry Size, Share, Trend, Opportunity & Forecast, Segmented By Type, By Disease, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球豬保健市場預計將從 2025 年的 31.8 億美元成長到 2031 年的 53.1 億美元，複合年成長率為 8.92%。

本產業涵蓋動物醫藥、疫苗、治療性飼料添加劑和診斷設備的研發、生產和供應，旨在保障豬隻的健康和生產力。推動該產業成長的關鍵因素包括全球對動物性蛋白質需求的不斷成長（這需要密集養殖方式）以及迫切需要減輕嚴重感染疾病造成的經濟損失。為了說明其中蘊含的巨大經濟價值，美國國家豬肉生產者委員會 (NPPC) 的報告顯示，到 2024 年，美國豬肉產業將為美國經濟貢獻超過 620 億美元。

市場概覽
預測期 2027-2031
市場規模：2025年 31.8億美元
市場規模：2031年 53.1億美元
複合年成長率：2026-2031年 8.92%
成長最快的細分市場 治療藥物
最大的市場 北美洲

儘管成長指標呈現積極態勢，但由於旨在應對抗菌素抗藥性的嚴格法律規範，該行業仍面臨許多挑戰。世界各地的監管機構正逐步限制抗生素的預防性使用，並對新產品的核准更為嚴格的標準。這些監管限制不僅縮小了農民可選擇的治療方案範圍，也增加了將新型動物醫藥解決方案推向國際市場的成本和複雜性。

市場促進因素

全球豬肉消費量的成長是推動生豬保健產業發展的主要因素，迫使養殖戶採用集約化農業技術，而這些技術需要嚴格的健康管理標準。隨著都市化和人口成長推動動物性蛋白質需求，生產者正在擴大營運規模，導致牲畜飼養密度增加。這就需要定期接種疫苗、驅蟲和使用藥用飼料添加劑，以確保豬群的存活率和運作效率。這種生產負擔反映在全球產量預測中，並直接轉化為獸藥產品需求的成長，以確保供應的連續性。例如，美國農業部於2024年4月發布的《畜牧與家禽：全球市場與貿易》報告預測，為滿足不斷成長的消費者需求，2024年全球豬肉產量將達到1.156億噸。

同時，跨境豬病疫情的日益增多迫使相關人員投入大量資源用於先進的診斷設備和預防性獸醫治療。非洲豬瘟和豬繁殖與呼吸症候群（PRRS）等病毒威脅對畜牧業資產構成嚴重風險，迫使該產業加強生物安全和疾病根除策略。這種對健康安全的優先重視需要對監測系統進行大量投資，以防止潛在的經濟崩潰。根據豬隻健康資訊中心於2024年1月發布的《2024財政年度產業計畫》，該機構專門撥款420萬美元用於疾病監測和豬隻健康監測，以應對這些生物威脅。此外，國際貿易統計數據也表明，維持無病貿易的經濟重要性顯而易見。據美國肉類出口協會稱，上年度美國豬肉出口額達到創紀錄的81.6億美元，凸顯了醫療保健在支持國際貿易流動方面發揮的關鍵作用。

市場挑戰

由於抗菌素抗藥性問題日益嚴峻，全球豬隻保健市場面臨日益嚴格的監管體系所帶來的重大挑戰。國際組織和各國政府對預防性抗生素的使用實施嚴格限制，同時核准設定了高標準。這種法規環境直接阻礙了市場成長，縮小了傳統抗菌藥物的市場規模，而這些藥物一直是生產商的主要收入來源。此外，更嚴格的產品核可要求導致臨床試驗規模更大、高成本更高，延長了新治療方法的上市時間，並減緩了養豬戶的整體創新步伐。

這些舉措的實際成效體現在抗生素使用量與歷史高點相比持續下降。由於生產商被迫遵守更嚴格的用藥通訊協定，一些具有重要醫療價值的藥物的使用量尚未恢復到先前的水平，這限制了製藥公司在該領域的商機。例如，根據美國國家豬肉協會2024年的數據，養豬業的抗生素使用量仍比2020年下降約18%。這些數據凸顯了監管要求如何從根本上限制了關鍵產品類型的銷售前景，最終抑制了整個產業的成長。

市場趨勢

隨著養殖戶更加重視早期檢測，以最大限度地減少非洲豬瘟等疫情造成的經濟損失，人工智慧驅動的疾病診斷設備的應用正在迅速改變全球養豬業的健康市場。這一趨勢超越了傳統的被動治療，強調即時和基因組監測，以便在病原體擴散到整個豬群之前將其檢測出來。該產業正增加對先進診斷系統的投資，這些系統利用人工智慧處理生物數據，並提供快速、準確的結果。這項轉變得到了大量資金的支持：根據《國家養豬戶》雜誌2025年2月刊報道，豬健康資訊中心（SHIC）將在2024年資助32個研究計劃，總額達399萬美元（創歷史新高），這些項目旨在推進基於基因組的診斷工具和疾病監測，以確保豬群健康。

同時，有機和無抗生素養殖的推廣正在重塑獸醫實踐，因為相關人員正在積極回應消費者對嚴格管理通訊協定和潔淨標示肉品的需求。這一趨勢正推動市場轉向疫苗和植物製劑等替代療法，以在不依賴傳統抗菌藥物的情況下維護動物福利。這種轉變在已開發市場已取得顯著成效，並促成了全球標準的建立。例如，英國獸醫協會（BVA）於2025年12月宣布，養豬業已成功將抗生素使用量在2020年至2024年間減少了30%，並設定了未來四年內再減少20%的新目標。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球豬保健市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 按類型（診斷藥物、治療藥物）
    • 疾病類型（滲出性皮膚炎（希臘豬病）、球蟲、呼吸道疾病、豬痢疾、豬小病毒、其他）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

6. 北美豬保健市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

7. 歐洲豬保健市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

8. 亞太地區豬保健市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

9. 中東和非洲豬保健市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

10. 南美洲豬保健市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章 全球豬保健市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale
  • Elanco Animal Health Incorporated
  • Innovative Diagnostics
  • Merck KgaA
  • Vetoquinol SA
  • Virbac SA
  • Zoetis Inc.
  • IDEXX Laboratories, Inc
  • Phibro Animal Health Corporation

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 23999

The Global Swine Healthcare Market is projected to expand from a valuation of USD 3.18 Billion in 2025 to USD 5.31 Billion by 2031, reflecting a compound annual growth rate of 8.92%. This sector comprises the creation, manufacture, and supply of veterinary medicines, vaccines, therapeutic feed additives, and diagnostic instruments designed to ensure the health and productivity of pig populations. Key factors fueling this growth include the rising global appetite for animal protein, which demands intensive farming methods, and the critical need to mitigate financial damages caused by severe infectious diseases. Highlighting the substantial economic stakes involved, the National Pork Producers Council reported that the United States pork industry added more than $62 billion to the economy in 2024.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 3.18 Billion
Market Size 2031USD 5.31 Billion
CAGR 2026-20318.92%
Fastest Growing SegmentTherapeutics
Largest MarketNorth America

Despite these positive growth indicators, the industry confronts significant hurdles due to rigid regulatory structures aimed at combating antimicrobial resistance. Regulatory bodies around the world are progressively limiting the preventative application of antibiotics and enforcing strict standards for the approval of new products. These regulatory constraints not only restrict the range of therapeutic choices available to farmers but also escalate the expenses and intricacies involved in introducing new veterinary medicinal solutions to the international market.

Market Driver

The escalating worldwide consumption of pork serves as a major engine for the growth of the swine healthcare industry, compelling farmers to implement intensive agricultural techniques that demand strict health management standards. As urbanization and population expansion drive up the need for animal protein, producers are expanding their operations, resulting in denser livestock populations that require the regular application of vaccines, parasiticides, and medicinal feed additives to ensure herd survival and operational efficiency. This production stress is reflected in global output forecasts, which link directly to a higher demand for veterinary health products to guarantee supply continuity. For example, the United States Department of Agriculture's 'Livestock and Poultry: World Markets and Trade' report from April 2024 projected that global pork production would hit 115.6 million tons in 2024 to satisfy this growing consumer appetite.

At the same time, the rising incidence of transboundary and infectious swine diseases compels stakeholders to commit substantial resources toward sophisticated diagnostic equipment and preventative veterinary treatments. Viral threats such as African Swine Fever and Porcine Reproductive and Respiratory Syndrome present serious risks to livestock assets, forcing the sector to emphasize biosecurity and disease elimination strategies. This prioritization of health security necessitates considerable investment in research and surveillance systems to prevent potential economic ruin. According to the Swine Health Information Center's '2024 Plan of Work' released in January 2024, the organization designated $4.2 million specifically for disease monitoring and swine health research to manage these biological threats. Moreover, the financial importance of maintaining disease-free trade status is substantial, as shown by international trade figures; the U.S. Meat Export Federation noted that U.S. pork exports achieved a record value of $8.16 billion during the previous year, highlighting healthcare's vital role in supporting global trade flows.

Market Challenge

The Global Swine Healthcare Market faces a major obstacle arising from increasingly strict regulatory systems intended to fight antimicrobial resistance. International organizations and governments are implementing rigorous restrictions on the preventative administration of antibiotics while setting high compliance benchmarks for new veterinary drugs. This regulatory climate directly hinders market growth by reducing the accessible market for traditional antimicrobial treatments, which have historically generated significant revenue for manufacturers. Additionally, the raised requirements for product authorization demand larger and more expensive clinical trials, thereby prolonging the timeline for launching new treatments and slowing the overall pace of innovation available to swine farmers.

The concrete effects of these stewardship initiatives are demonstrated by the continued reduction in antibiotic usage volumes compared to past peaks. As producers are forced to adhere to tighter usage protocols, the uptake of medically significant drugs has not rebounded to previous levels, thereby capping the revenue opportunities for pharmaceutical firms within this sector. For example, data from the National Pig Association in 2024 indicated that antibiotic use in the pig industry remained approximately 18% below the figures observed in 2020. This data point highlights how regulatory demands have fundamentally limited the sales prospects of core product categories, consequently moderating the industry's overall growth rate.

Market Trends

The integration of AI-powered disease diagnostic instruments is rapidly reshaping the Global Swine Healthcare Market as producers focus on early identification to minimize financial damages from outbreaks such as African Swine Fever. This movement transcends conventional reactive therapies, placing importance on real-time monitoring and genomic surveillance to detect pathogens before they propagate throughout a herd. The sector is seeing increased investment in advanced diagnostic systems that utilize artificial intelligence to process biological data for quicker and more precise outcomes. This transition is supported by substantial funding; as reported by National Hog Farmer in February 2025, the Swine Health Information Center financed 32 research initiatives totaling a record $3.99 million in 2024, explicitly aiming to advance genome-based diagnostic tools and disease surveillance to ensure herd well-being.

Simultaneously, the growth of organic and antibiotic-free farming methods is redefining veterinary procedures as stakeholders conform to rigorous stewardship protocols and consumer demands for clean-label meat products. This trend steers the market toward alternative treatment approaches, such as the application of vaccines and phytogenics, to uphold animal welfare without dependence on traditional antimicrobials. Forward-thinking markets are showing considerable success in this shift, establishing standards for global adherence. For example, according to the British Veterinary Association in December 2025, the pig industry successfully lowered antibiotic use by 30% from 2020 to 2024, leading to the setting of a new goal to reduce usage by a further 20% over the subsequent four years.

Key Market Players

  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale
  • Elanco Animal Health Incorporated
  • Innovative Diagnostics
  • Merck KgaA
  • Vetoquinol SA
  • Virbac S.A.
  • Zoetis Inc.
  • IDEXX Laboratories, Inc
  • Phibro Animal Health Corporation

Report Scope

In this report, the Global Swine Healthcare Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Swine Healthcare Market, By Type

  • Diagnostics
  • Therapeutics

Swine Healthcare Market, By Disease

  • Exudative dermatitis (greasy pig disease)
  • Coccidiosis
  • Respiratory Diseases
  • Swine Dysentery
  • Porcine Parvovirus
  • Other

Swine Healthcare Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Swine Healthcare Market.

Available Customizations:

Global Swine Healthcare Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Swine Healthcare Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Diagnostics, Therapeutics)
    • 5.2.2. By Disease (Exudative dermatitis (greasy pig disease), Coccidiosis, Respiratory Diseases, Swine Dysentery, Porcine Parvovirus, Other)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Swine Healthcare Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Disease
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Swine Healthcare Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Disease
    • 6.3.2. Canada Swine Healthcare Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Disease
    • 6.3.3. Mexico Swine Healthcare Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Disease

7. Europe Swine Healthcare Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Disease
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Swine Healthcare Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Disease
    • 7.3.2. France Swine Healthcare Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Disease
    • 7.3.3. United Kingdom Swine Healthcare Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Disease
    • 7.3.4. Italy Swine Healthcare Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Disease
    • 7.3.5. Spain Swine Healthcare Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Disease

8. Asia Pacific Swine Healthcare Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Disease
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Swine Healthcare Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Disease
    • 8.3.2. India Swine Healthcare Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Disease
    • 8.3.3. Japan Swine Healthcare Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Disease
    • 8.3.4. South Korea Swine Healthcare Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Disease
    • 8.3.5. Australia Swine Healthcare Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Disease

9. Middle East & Africa Swine Healthcare Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Disease
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Swine Healthcare Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Disease
    • 9.3.2. UAE Swine Healthcare Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Disease
    • 9.3.3. South Africa Swine Healthcare Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Disease

10. South America Swine Healthcare Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Disease
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Swine Healthcare Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Disease
    • 10.3.2. Colombia Swine Healthcare Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Disease
    • 10.3.3. Argentina Swine Healthcare Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Disease

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Swine Healthcare Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Boehringer Ingelheim International GmbH
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Ceva Sante Animale
  • 15.3. Elanco Animal Health Incorporated
  • 15.4. Innovative Diagnostics
  • 15.5. Merck KgaA
  • 15.6. Vetoquinol SA
  • 15.7. Virbac S.A.
  • 15.8. Zoetis Inc.
  • 15.9. IDEXX Laboratories, Inc
  • 15.10. Phibro Animal Health Corporation

16. Strategic Recommendations

17. About Us & Disclaimer